+ Filter
Loading...
Custom Services order now ship next day

CEACAM5

Anti-CEACAM5 Recombinant Antibody Products

More Infomation

Can't find the products you're looking for? Try to filter in the left sidebar.Filter By Tag

More Infomation

Our customer service representatives are available 24 hours a day, from Monday to Sunday. Contact Us

For Research Use Only. Not For Clinical Use.


Creative Biolabs offers a comprehensive selection of premium anti-CEACAM5 antibodies tailored to meet the diverse needs of your research. Our antibodies are characterized by their outstanding specificity, sensitivity, and strong affinity for CEACAM5, making them ideal for various applications. We pride ourselves on our exceptional customer support team, which is ready to assist you with product recommendations, technical questions, and order management, ensuring that your research journey is as smooth and productive as possible.

CEACAM5: A Potential Lifeline in Cancer Treatment

CEACAM5, a cell surface glycoprotein frequently overexpressed in various cancers, has emerged as a potential therapeutic target. Its elevated expression is associated with tumor progression, invasion, and metastasis. By understanding the role of CEACAM5 in cancer biology, researchers are developing innovative strategies to disrupt its function such as antibody-based therapies, vaccines, small molecule inhibitors, etc. Continued research and development are essential to fully realize the potential of CEACAM5 as a therapeutic target and improve outcomes for cancer patients.

Alternative Names

CEA Cell Adhesion Molecule 5; Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; Carcinoembryonic Antigen Related Cell Adhesion Molecule 5; Carcinoembryonic Antigen; CD66e; CD66e Antigen; Meconium Antigen 100.

Background

This gene encodes a cell surface glycoprotein that represents the founding member of the carcinoembryonic antigen (CEA) family of proteins. The encoded protein is used as a clinical biomarker for gastrointestinal cancers and may promote tumor development through its role as a cell adhesion molecule. Additionally, the encoded protein may regulate differentiation, apoptosis, and cell polarity. This gene is present in a CEA family gene cluster on chromosome 19. Alternative splicing results in multiple transcript variants.

Anti-CEACAM5 rAb Products

Creative Biolabs excels in providing premium anti-CEACAM5 antibodies, engineered for exceptional accuracy and efficacy in scientific research. Our antibodies are carefully developed to ensure focused performance while minimizing cross-reactivity with other proteins. With a diverse range of customizable formats at your disposal, researchers can select the antibody that aligns perfectly with their specific experimental requirements, facilitating deeper and more meaningful scientific discoveries.

Table 1. Featured anti-CEACAM5 recombinant antibody products at Creative Biolabs.

Cat. No. Product Name Target Species Host Species Applications
TAB-408LC Anti-Human CEACAM5 Recombinant Antibody (A5B7) Human Mouse WB, ELISA, etc.
MOB-1138z Mouse Anti-CEACAM5 Recombinant Antibody (clone 32B10) Human Mouse IgG1, κ WB, IP, IF, FC
TAB-428LC Anti-Human CEACAM5 Recombinant Antibody (COL-Human 10) Human Mouse FC, WB
TAB-416LC Human Anti-CEACAM5 Recombinant Antibody Human Human IgG1 ELISA, FC, Inhib
TAB-703 Anti-Human CEACAM5 Recombinant Antibody (Altumomab) Human Mouse IF, IP, Neut, FuncS, ELISA, FC, IHC, etc.

Creative Quality Control

Creative Biolabs is committed to offering researchers a diverse selection of premium anti-CEACAM5 antibodies. Each antibody undergoes rigorous testing to ensure it adheres to top-quality standards and achieves optimal performance across various applications. Our unwavering focus on quality ensures that our products comply with the highest industry benchmarks, delivering reliable and consistent results that support the advancement of your scientific research.

Fig.1 SDS-PAGE analysis. (Creative Biolabs Original)Fig.1 SDS-PAGE analysis of anti-CEACAM5 antibody
(Cat# TAB-408LC, Creative Biolabs).

Fig.2 SEC-HPLC analysis. (Creative Biolabs Original)Fig.2 SEC-HPLC analysis of anti-CEACAM5 antibody
(Cat# TAB-408LC, Creative Biolabs).

Fig.3 WB analysis. (Creative Biolabs Original)Fig.3 WB analysis of anti-CEACAM5 antibody
(Cat# TAB-408LC, Creative Biolabs).

Fig.4 ELISA analysis. (Creative Biolabs Original)Fig.4 ELISA analysis of anti-CEACAM5 antibody
(Cat# TAB-408LC, Creative Biolabs).

Customer Reviews

Excellent
Ji***g
Anti-Human CEACAM5 Recombinant Antibody (A5B7) (TAB-408LC)
My experience with Creative Biolabs' anti-CEACAM5 antibody in my colorectal cancer research has been outstanding. The antibody exhibits exceptional performance, providing consistent and reproducible results across both Western blotting and immunohistochemistry applications. Its remarkable specificity and sensitivity have greatly aided in accurately detecting CEACAM5 expression in tumor samples. I wholeheartedly recommend this antibody to fellow researchers in this area.
10/Oct/2022
Excellent
Jo***y
Mouse Anti-CEACAM5 Recombinant Antibody (clone 32B10) (MOB-1138z)
As a researcher studying breast cancer, I've found Creative Biolabs' anti-CEACAM5 antibody to be an essential tool. Its excellent performance in flow cytometry has allowed me to accurately quantify CEACAM5 expression on tumor cells. The antibody's low background staining and high signal-to-noise ratio have significantly enhanced the quality of my data. I'm confident in the reliability and consistency of this product.
12/Nov/2022
Excellent
La***a
Anti-Human CEACAM5 Recombinant Antibody (COL-Human 11) (TAB-432LC)
I've been using Creative Biolabs' anti-CEACAM5 antibody in my studies on lung cancer, and I've been very satisfied with its performance in immunofluorescence staining. The antibody consistently produces clear and well-defined staining patterns, allowing me to visualize CEACAM5 localization within tumor cells. Its high affinity and specificity have been crucial for my research, and I would definitely recommend this antibody to others working in this area.
11/Sep/2023

rAb Production

Creative Biolabs harnesses a cutting-edge recombinant antibody platform that employs innovative genetic engineering techniques to produce premium anti-CEACAM5 antibodies. This groundbreaking method facilitates efficient and adaptable antibody production, guaranteeing a consistent supply of antibodies customized to fulfill the varied needs of researchers across multiple applications.

Featured Anti-CEACAM5 Recombinant Antibody Production PlatformsFig.5 Milligram-scale. (Creative Biolabs Original)
Fig.5 Milligram-scale anti-CEACAM5 recombinant antibody production.

Fig.6 Gram-scale. (Creative Biolabs Original)Fig.6 Gram-scale anti-CEACAM5 recombinant antibody production.

rAb Modalities

Creative Biolabs provides an extensive array of top-notch anti-CEACAM5 recombinant antibodies with diverse formats, designed to cater to your unique research requirements with flexibility and precision.

Fig.7 CEACAM5 antibody production and modalities. (Creative Biolabs Original)Fig.7 Full-length anti-CEACAM5 recombinant antibody production and modalities.

CEACAM5-Targeted Drug Information

Table 2. Public drug targeting CEACAM5.

Highest Phase Mechanism of Action Product Category Condition Organization
Pre-Registered Anti-CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; CD66e) Monoclonal Antibodies Hybritech (Originator)
Phase III Drugs Targeting Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA; CD66e) Chimeric Monoclonal Antibodies
Fluorescence Imaging Agents
Cancer, colon
Cancer, colorectal
Cancer, colorectal, metastatic
Cancer, metastatic (to brain)
Cancer, metastatic (to lung)
Cancer, pancreas
Cancer, rectum
Digestive-gastrointestinal cancer
Institut Regional du Cancer Montpellier (Originator)
Institut Regional du Cancer Montpellier
SurgiMab (Originator)
Phase III Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers
HER2 (erbB2)-Directed Immunity Inducers
Melanoma-Associated Antigen 3 (MAGEA3; MAGE-3)-Directed Immunity Inducers
Signal Transduction Modulators
Cancer Immunotherapy
Cancer Vaccines
Peptides
Peptide Vaccines
Cancer, colorectal
Cancer, lung
Cancer, lung (non-small cell) (NSCLC)
Cancer, ovary
Cancer, pancreas
Cancer, pancreas (ductal adenocarcinoma)
Chong Kun Dang Bio
Epimmune (Takeda)
IDM (Takeda)
OSE Immunotherapeutics
Ose Pharma (OSE Immunotherapeutics)
Rafa Laboratories
Takeda (Originator)
Phase III Anti-CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; CD66e) Anti-Idiotype Vaccines
Cancer Immunotherapy
Cancer Vaccines
Murine Monoclonal Antibodies
Cancer, colorectal
Cancer, colorectal, metastatic
Cancer, lung (non-small cell) (NSCLC)
National Cancer Institute
Titan (Originator)
Phase II Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers
Mucin-1 (MUC1)-Directed Immunity Inducers
Adenoviral Vectors
Cancer Immunotherapy
Cancer Vaccines
Recombinant Vector Vaccines
Lynch syndrome ImmunityBio (Originator)
National Cancer Institute
Phase II Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers
Mucin-16 (MUC16; CA125)-Directed Immunity Inducers
Allogenic Cellular Vaccines
Autologous Cellular Vaccines
Cancer Immunotherapy
Cancer Vaccines
Polypeptides, from 41 AA
Subunit Vaccines
Cancer, breast Elliott-Elliott-Head Breast Cancer (Originator)
OncImmune (Originator)
Phase II Anti-CEACAM5 (Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5; CD66e) Bispecific Antibodies
Cancer Immunotherapy
Monoclonal Antibodies
Cancer, thyroid, medullary Centre Hospitalier Universitaire Nantes
Gilead (Originator)
Phase II Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers Cancer Immunotherapy
Cancer Vaccines
DNA Vaccines
Cancer of unspecified body location-system Medical Marketing Int (d/b/a Oncosense) (Originator)
Phase II Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers Cancer Immunotherapy
Cancer Vaccines
Recombinant Vector Vaccines
Cancer, breast
Cancer, breast, metastatic
Cancer, colorectal
Cancer, colorectal, metastatic
Cancer, lung
Cancer, metastatic (to liver)
Cancer, pancreas
Cancer, solid tumor
National Cancer Institute
Sanofi Pasteur
Therion (Originator)
Phase II Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5 (CEACAM5; CEA)-Directed Immunity Inducers Cancer Immunotherapy
Cancer Vaccines
Recombinant Vector Vaccines
Cancer, colorectal
Cancer, colorectal, metastatic
Immunological Disorders
National Cancer Institute (Originator)
Sanofi Pasteur
Therion

(Disclaimer: The information in this table is just for knowledge sharing and not for marketing or sales purposes.)

Creative Biolabs is dedicated to advancing antibody research by integrating extensive theoretical knowledge with practical experience, ensuring the delivery of high-quality anti-CEACAM5 antibodies at competitive prices. We invite you to explore our diverse selection of anti-CEACAM5 antibody products and learn how they can support your research objectives. Please don't hesitate to contact us for more information.

  • 0
  • 0
Cart
    Go to compare

    Go to compare